AKT1 and asthma: In conclusion, our data clearly show that OBE inhibits the asthma phenotype in a clinically relevant murine model of asthma, at least in part, via inhibition of Th2 cytokine profile, via inhibition of the EGFR/ERK/1/2/AKT signaling pathway.